TerminatedNot Applicable

Diabetes and Smoking Cessation: a Gender-Oriented Study

Stopped: Recruitment rate too low (COVID-19 pandemic), end of funding

Switzerland48 participantsStarted 2018-03-01

Plain-language summary

People with diabetes still smoke at equivalent rates as non-diabetics. There is lack of evidence regarding interventions for smoking cessation among individuals with diabetes. The aim of this project is to assess the 12 months efficacy of a smoking cessation intervention tailored to diabetes and gender specificities, in a population of 500 smokers with type 2 diabetes. The secondary objectives are to assess the impact of smoking cessation on anthropometric outcomes, diabetes control and renal function and fecal microbiota.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Informed Consent as documented by signature; * Having smoked \> 100 cigarettes during his/her entire life and currently smoking cigarettes (no minimal threshold); * Having been diagnosed with a type 2 diabetes; * Being ≥ 18 years old; * Speaking and understanding French Exclusion Criteria: * Not being able to give an informed consent and follow the procedure of the study (due to dementia, psychological disorder, language problem); * Being pregnant or breastfeeding; * Being enrolled in another smoking cessation study or program or in a multi-behavioral program including smoking cessation; * Enrolment of the investigator or other research collaborators, their family members, employees and other dependent persons; * Planning to move out of Switzerland within the next year.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Continuous smoking abstinence

Timeframe: Measured at 52 weeks

Trial details

NCT IDNCT03426423

SponsorCarole Clair

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-15

View on ClinicalTrials.gov More Smoking Cessation trials